Effects of fluoroquinolone on mitral and aortic regurgitation: A systematic review and meta-analysis
Article Sidebar
Main Article Content
Abstract
This study aimed to systematically review and meta-analyze the effects of fluoroquinolones on mitral and aortic regurgitation. Seven electronic databases were searched for relevant research data published in English and Thai between the database’s inception and September 30, 2022, including additional records from Silpakorn University and Chulalongkorn University’s online theses databases. This systematic review included studies that compared the effects of fluoroquinolones and other antibiotic classes on the occurrence of mitral and aortic valve regurgitation. Subsequently, the quality of the research was evaluated using the Newcastle-Ottawa Quality Assessment Scale. Of the 2,891 articles identified, two eligible studies were included in the analysis. The meta-analysis examined different exposure periods and discovered that individuals who received fluoroquinolones within 30 days and within one year had a similar risk of developing mitral and aortic valve regurgitation compared to those who received other groups of antibiotics. Specifically, the risk of mitral and aortic regurgitation associated with fluoroquinolones was comparable to that of amoxicillin and macrolides. Overall, the meta-analysis found no association between fluoroquinolone use and the development of mitral and aortic regurgitation.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Carino, D., Zafar, M. A., Singh, M., Ziganshin, B. A., & Elefteriades, J. A. (2019). Fluoroquinolones and aortic diseases: Is there a connection. Aorta (Stamford), 7(2), 35–41. https://doi.org/10.1055/s-0039-1693468
Centre for Reviews and Dissemination. (2009). CRD’s guidance for undertaking reviews in health care. York Publishing Services.
Chandy, S. J., Thomas, K., Mathai, E., Antonisamy, B., Holloway, K. A., & Lundborg, C. S. (2013). Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: A repeated cross-sectional study in Vellore, south India. Journal of Antimicrobial Chemotherapy, 68(1), 229–236. https://doi.org/10.1093/jac/dks355
Ernster, V. L. (1994). Nested case-control studies. Preventive Medicine, 23(5), 587–590. https://doi.org/10.1006/pmed.1994.1093
Etminan, M., Forooghian, F., Brophy, J. M., Bird, S. T., & Maberley, D. (2012). Oral fluoroquinolones and the risk of retinal detachment. JAMA Neurology, 307(13), 1414–1419. https://doi.org/10.1001/jama.2012.383
Etminan, M., Sodhi, M., Ganjizadeh-Zavareh, S., Carleton, B., Kezouh, A., & Brophy, J. M. (2019). Oral fluoroquinolones and ris of mitral and aortic regurgitation. Journal of the American College of Cardiology, 74(11), 1444–1450. https://doi.org/10.1016/j.jacc.2019.07.035
Greenhoot, A. F., & Dowsett, C. J. (2012). Secondary data analysis: An important tool for addressing developmental questions. Journal of Cognition and Development, 13(1), 2–18. https://doi.org/10.1080/15248372.2012.646613
Hull University Teaching Hospitals. (2019). Fluoroquinolone antibiotics (ciprofloxacin, moxifloxacin, levofloxacin, ofloxacin) what you need to know. https://www.hey.nhs.uk/patient-leaflet/fluoroquinolone-antibiotics-ciprofloxacin-moxifloxacin-levofloxacin-ofloxacin-what-you-need-to-know/
Kabbani, S., Hersh, A. L., Shapiro, D. J., Fleming-Dutra, K. E., Pavia, A. T., & Hicks, L. A. (2018). Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits. Clinical Infectious Diseases, 67(1), 134–136. https://doi.org/10.1093/cid/ciy035
Ket-Aim, S., Suksomboon, N., & Poolsup, N. (2005). ABC of meta-analysis. https://www.thaihp.org/index.php?option=other_detail&lang=th&id=24&sub=26
La-ongsuwan, S., Jaemsak, K., Chor.soraphong, T., Kaewbutra, V., & Laosuebsakhunthai, W. (2017). Correlation between the antimicrobials utilization and antimicrobial-resistance in Prasat Neurological Institute. Thai Bulletin of Pharmaceutical Sciences, 12(2), 21–29. https://doi.org/10.69598/tbps.12.2.21-29 [in Thai]
Lee, Y. H. (2019). Strengths and limitations of meta-analysis. The Korean Journal of Medicine, 94(5), 391–395. https://doi.org/10.3904/kjm.2019.94.5.391
Pasternak, B., Inghammar, M., & Svanström, H. (2018). Fluoroquinolone use and risk of aortic aneurysm and dissection: Nationwide cohort study. BMJ, 360, Article k678. https://doi.org/10.1136/bmj.k678
PRISMA. (2021). PRISMA flow diagram. http://prisma-statement.org/PRISMAStatement/FlowDiagram
Saokaew, S. (2016). Understanding and interpretation of meta-analysis study. Chiangrai Medical Journal, 8(1/2559), 139–151.
Schjøtt, J., & Messner, T. (2018). Ciprofloxacin and acute aortic valve damage. Medical Hypotheses, 121, 35. https://doi.org/10.1016/j.mehy.2018.09.013
Sedgwick, P. (2014). Nested case-control studies: Advantages and disadvantages. BMJ, 348, Article g1532. https://doi.org/10.1136/bmj.g1532
Strange, J. E., Holt, A., Blanche, P., Gislason, G., Torp-Pedersen, C., Christensen, D. M., Hansen, M. L., Lamberts, M., Schou, M., Olesen, J. B., Fosbøl, E. L., Køber, L., & Rasmussen, P. V. (2021). Oral fluoroquinolones and risk of aortic or mitral regurgitation: A nationwide nested case-control study. European Heart Journal, 42(30), 2899–2908. https://doi.org/10.1093/eurheartj/ehab374
Tanne, J. H. (2008). FDA adds “black box” warning label to fluoroquinolone antibiotics. BMJ, 337, Article a816. https://doi.org/10.1136/bmj.a816
Thammatacharee, N., Waleekhachonloet, O., & Limwattananon, C. (2017). Antibacterials prescribed to universal health coverage beneficiaries in outpatient departments, Thailand. Journal of Health Systems Research, 11(4), 471–480. https://kb.hsri.or.th/dspace/handle/11228/4811?show=full [in Thai]
van Enst, W. A., Ochodo, E., Scholten, R. J. P. M., Hooft, L., & Leeflang, M. M. (2014). Investigation of publication bias in meta-analyses of diagnostic test accuracy: A meta-epidemiological study. BMC Medical Research Methodology, 14(1), Article 70. https://doi.org/10.1186/1471-2288-14-70
Wells, G. A., Shea, B., O’Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Windle, P. E. (2010). Secondary data analysis: Is it useful and valid? Journal of PeriAnesthesia Nursing, 25(5), 322–324. https://doi.org/10.1016/j.jopan.2010.07.005
